NEW

UVDI-360 Room Sanitizer Inactivates SARS-CoV-2 at 12 Feet Distance in 5 Minutes

UltraViolet Devices Inc. (UVDI) has announced that its UVDI-360 Room Sanitizer achieved greater than 99.99%, or 4log10, inactivation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in 5 minutes at a distance of 12 feet (3.65 meters).

oneSOURCE Creates Free Resource Page with Up-to-Date COVID-19 Vaccine Information

Today, oneSOURCE, an RLDatix company and leading healthcare management solution, announced a new COVID-19 vaccine resource page to assist healthcare professionals during the initial administration phases of the vaccine.

STERIS to Acquire Cantel Medical

STERIS plc and Cantel Medical Corp. announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary. Cantel is a global provider of infection prevention products and services primarily to endoscopy and dental Customers.

NEC Releases ‘WISE VISION Endoscopy’ in Europe and Japan

NEC Corporation has announced the development of “WISE VISION Endoscopy,” an AI diagnosis-support medical device software for colonoscopies, which is being released in Japan and is expected to soon be available in Europe.

Silvasorb Antimicrobial Wound Gel

Medline’s SilvaSorb is intended for lightly draining wounds in need of an antimicrobial barrier. The gel provides continuous antimicrobial protection, does not stain, is gentle on patient skin and offers advanced fluid management and extended wear time, according to Medline’s company research. The gel is indicated for the management of pressure ulcers, partial and full-thickness wounds, leg ulcers, diabetic foot ulcers, graft wounds and donor sites, skin tears, surgical wounds and second-degree burns. Sheets can be left in place for up to seven days, while the amorphous gel can be left in place for up to three days.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X